Results 241 to 250 of about 14,970 (304)
Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods. [PDF]
Didehvar K +4 more
europepmc +1 more source
Association of VTN Genotype with Plasminogen Activator Inhibitor-1 Activity in Late-Onset Alzheimer's Disease. [PDF]
Agirbasli D +3 more
europepmc +1 more source
M1 protein from group A <i>Streptococcus</i> affects fibrin clot formation, structure, and fibrinolytic potential. [PDF]
Cherrington S +4 more
europepmc +1 more source
Role of Clot Formation and Plasminogen Activation in Lower Urinary Tract Pathologies. [PDF]
Molina JJ, Flores-Mireles AL.
europepmc +1 more source
Role of αv Integrins in TGF-β-Mediated Renal Fibrosis. [PDF]
Chang Y.
europepmc +1 more source
From inhibition to regulation: serpins in health and disease. [PDF]
Kattner AA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biochemistry, 1986
The amidolytic plasmin activity of a mixture of tissue plasminogen activator (tPA) and plasminogen is enhanced by heparin at therapeutic concentrations. Heparin also increases the activity in mixtures of urokinase-type plasminogen activator (uPA) and plasminogen but has no effect on streptokinase or plasmin. Direct analyses of plasminogen activation by
P, Andrade-Gordon, S, Strickland
openaire +2 more sources
The amidolytic plasmin activity of a mixture of tissue plasminogen activator (tPA) and plasminogen is enhanced by heparin at therapeutic concentrations. Heparin also increases the activity in mixtures of urokinase-type plasminogen activator (uPA) and plasminogen but has no effect on streptokinase or plasmin. Direct analyses of plasminogen activation by
P, Andrade-Gordon, S, Strickland
openaire +2 more sources

